APO Research
Talk to an analyst

APO RESEARCH · REPORT

Yellow Nail Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Yellow Nail Syndrome Treatment Industry Research Report 2026

31 December 2025126 pages

Choose your research edition.

Industry ResearchYellow Nail Syndrome Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Yellow Nail Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Yellow Nail Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Yellow Nail Syndrome Treatment Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Yellow Nail Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Yellow Nail Syndrome Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Yellow Nail Syndrome Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Yellow Nail Syndrome Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Yellow Nail Syndrome Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Yellow Nail Syndrome Treatment include Abbott, Sanofi, Johnson & Johnson, Novartis, Merck, Merck, Mylan, Roche and Pfizer, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Yellow Nail Syndrome Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Yellow Nail Syndrome Treatment.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Yellow Nail Syndrome Treatment Market by Company

Abbott

Sanofi

Johnson & Johnson

Novartis

Merck

Merck

Mylan

Roche

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Teva Pharmaceutical

Sun Pharmaceutical

Sumitomo Corporation

Enzon Pharmaceuticals

Cipla

Allergan

Yellow Nail Syndrome Treatment Segment by Type

Capsule

Cream

Tablet

Injection

Others

Yellow Nail Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Yellow Nail Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Nail Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Nail Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Nail Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Yellow Nail Syndrome Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 7. Global Yellow Nail Syndrome Treatment Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 9. Global Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 11. Global Yellow Nail Syndrome Treatment Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 13. Global Yellow Nail Syndrome Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Yellow Nail Syndrome Treatment Market Share by Region (2021-2026) Table 16. Global Yellow Nail Syndrome Treatment Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Yellow Nail Syndrome Treatment Market Share by Region (2027-2032) Table 18. Yellow Nail Syndrome Treatment Industry Trends Table 19. Yellow Nail Syndrome Treatment Industry Drivers Table 20. Yellow Nail Syndrome Treatment Industry Opportunities and Challenges Table 21. Yellow Nail Syndrome Treatment Market Restraints Table 22. Global Top Yellow Nail Syndrome Treatment Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Yellow Nail Syndrome Treatment Revenue Market Share by Players (2021-2026) Table 24. Global Yellow Nail Syndrome Treatment Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Yellow Nail Syndrome Treatment, Headquarters and Area Served Table 26. Global Yellow Nail Syndrome Treatment Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Yellow Nail Syndrome Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Yellow Nail Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 48. Abbott Yellow Nail Syndrome Treatment Product Portfolio Table 49. Abbott Recent Developments Table 50. Sanofi Company Information Table 51. Sanofi Business Overview Table 52. Sanofi Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 53. Sanofi Yellow Nail Syndrome Treatment Product Portfolio Table 54. Sanofi Recent Developments Table 55. Johnson & Johnson Company Information Table 56. Johnson & Johnson Business Overview Table 57. Johnson & Johnson Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 58. Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio Table 59. Johnson & Johnson Recent Developments Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 63. Novartis Yellow Nail Syndrome Treatment Product Portfolio Table 64. Novartis Recent Developments Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 68. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 69. Merck Recent Developments Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 73. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 74. Merck Recent Developments Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 78. Mylan Yellow Nail Syndrome Treatment Product Portfolio Table 79. Mylan Recent Developments Table 80. Roche Company Information Table 81. Roche Business Overview Table 82. Roche Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 83. Roche Yellow Nail Syndrome Treatment Product Portfolio Table 84. Roche Recent Developments Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 88. Pfizer Yellow Nail Syndrome Treatment Product Portfolio Table 89. Pfizer Recent Developments Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 93. GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio Table 94. GlaxoSmithKline Recent Developments Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 98. Bayer Yellow Nail Syndrome Treatment Product Portfolio Table 99. Bayer Recent Developments Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 103. AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio Table 104. AstraZeneca Recent Developments Table 105. Teva Pharmaceutical Company Information Table 106. Teva Pharmaceutical Business Overview Table 107. Teva Pharmaceutical Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 108. Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 109. Teva Pharmaceutical Recent Developments Table 110. Sun Pharmaceutical Company Information Table 111. Sun Pharmaceutical Business Overview Table 112. Sun Pharmaceutical Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 113. Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 114. Sun Pharmaceutical Recent Developments Table 115. Sumitomo Corporation Company Information Table 116. Sumitomo Corporation Business Overview Table 117. Sumitomo Corporation Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 118. Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio Table 119. Sumitomo Corporation Recent Developments Table 120. Enzon Pharmaceuticals Company Information Table 121. Enzon Pharmaceuticals Business Overview Table 122. Enzon Pharmaceuticals Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 123. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio Table 124. Enzon Pharmaceuticals Recent Developments Table 125. Cipla Company Information Table 126. Cipla Business Overview Table 127. Cipla Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 128. Cipla Yellow Nail Syndrome Treatment Product Portfolio Table 129. Cipla Recent Developments Table 130. Allergan Company Information Table 131. Allergan Business Overview Table 132. Allergan Revenue in Yellow Nail Syndrome Treatment Business (2021-2026) & (US$ Million) Table 133. Allergan Yellow Nail Syndrome Treatment Product Portfolio Table 134. Allergan Recent Developments Table 135. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Yellow Nail Syndrome Treatment Product Image Figure 5. Global Yellow Nail Syndrome Treatment Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Yellow Nail Syndrome Treatment Market Share by Type: 2025 VS 2032 Figure 7. Capsule Product Figure 8. Cream Product Figure 9. Tablet Product Figure 10. Injection Product Figure 11. Others Product Figure 12. Global Yellow Nail Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Yellow Nail Syndrome Treatment Market Share by Application: 2025 VS 2032 Figure 14. Hospital Product Figure 15. Clinic Product Figure 16. Others Product Figure 17. Global Yellow Nail Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 18. Global Yellow Nail Syndrome Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Yellow Nail Syndrome Treatment Market Share by Region: 2025 VS 2032 Figure 20. Global Yellow Nail Syndrome Treatment Market Share by Players in 2025 Figure 21. Global Yellow Nail Syndrome Treatment Manufacturers Established Date Figure 22. Global Top 5 and 10 Yellow Nail Syndrome Treatment Players Market Share by Revenue in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. North America Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 26. United States Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Canada Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Mexico Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 29. Europe Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 31. Germany Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. France Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. U.K. Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Italy Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Spain Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Russia Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Netherlands Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Nordic Countries Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 41. China Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Japan Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. South Korea Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 46. Australia Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. China Taiwan Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Southeast Asia Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 51. Brazil Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Argentina Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Chile Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Colombia Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Peru Yellow Nail Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Abbott Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 57. Sanofi Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 58. Johnson & Johnson Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 59. Novartis Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 60. Merck Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 61. Merck Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 62. Mylan Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 63. Roche Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 64. Pfizer Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 65. GlaxoSmithKline Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 66. Bayer Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 67. AstraZeneca Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 68. Teva Pharmaceutical Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 69. Sun Pharmaceutical Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 70. Sumitomo Corporation Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 71. Enzon Pharmaceuticals Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 72. Cipla Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026) Figure 73. Allergan Revenue Growth Rate in Yellow Nail Syndrome Treatment Business (2021-2026)

Scope & coverage.

Types
  • Capsule
  • Cream
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Merck
  • Mylan
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sumitomo Corporation
  • Enzon Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Yellow Nail Syndrome Treatment by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Capsule
  5. 2.2.3 Cream
  6. 2.2.4 Tablet
  7. 2.2.5 Injection
  8. 2.2.6 Others
  9. 2.3 Yellow Nail Syndrome Treatment by Application
  10. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  11. 2.3.2 Hospital
  12. 2.3.3 Clinic
  13. 2.3.4 Others
  14. 2.4 Assumptions and Limitations
3 Yellow Nail Syndrome Treatment Breakdown Data by Type
  1. 3.1 Global Yellow Nail Syndrome Treatment Historic Market Size by Type (2021-2026)
  2. 3.2 Global Yellow Nail Syndrome Treatment Forecasted Market Size by Type (2027-2032)
4 Yellow Nail Syndrome Treatment Breakdown Data by Application
  1. 4.1 Global Yellow Nail Syndrome Treatment Historic Market Size by Application (2021-2026)
  2. 4.2 Global Yellow Nail Syndrome Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Yellow Nail Syndrome Treatment Market Perspective (2021-2032)
  2. 5.2 Global Yellow Nail Syndrome Treatment Growth Trends by Region
  3. 5.2.1 Global Yellow Nail Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Yellow Nail Syndrome Treatment Historic Market Size by Region (2021-2026)
  5. 5.2.3 Yellow Nail Syndrome Treatment Forecasted Market Size by Region (2027-2032)
  6. 5.3 Yellow Nail Syndrome Treatment Market Dynamics
  7. 5.3.1 Yellow Nail Syndrome Treatment Industry Trends
  8. 5.3.2 Yellow Nail Syndrome Treatment Market Drivers
  9. 5.3.3 Yellow Nail Syndrome Treatment Market Challenges
  10. 5.3.4 Yellow Nail Syndrome Treatment Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Yellow Nail Syndrome Treatment Players by Revenue
  2. 6.1.1 Global Top Yellow Nail Syndrome Treatment Players by Revenue (2021-2026)
  3. 6.1.2 Global Yellow Nail Syndrome Treatment Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Yellow Nail Syndrome Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Yellow Nail Syndrome Treatment Head Office and Area Served
  6. 6.4 Global Yellow Nail Syndrome Treatment Players, Product Type & Application
  7. 6.5 Global Yellow Nail Syndrome Treatment Manufacturers Established Date
  8. 6.6 Global Yellow Nail Syndrome Treatment Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 7.2 North America Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  4. 7.4 North America Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 8.2 Europe Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  4. 8.4 Europe Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 9.2 Asia-Pacific Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 10.2 South America Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  4. 10.4 South America Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 11.2 Middle East & Africa Yellow Nail Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Abbott
  2. 12.1.1 Abbott Company Information
  3. 12.1.2 Abbott Business Overview
  4. 12.1.3 Abbott Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  5. 12.1.4 Abbott Yellow Nail Syndrome Treatment Product Portfolio
  6. 12.1.5 Abbott Recent Developments
  7. 12.2 Sanofi
  8. 12.2.1 Sanofi Company Information
  9. 12.2.2 Sanofi Business Overview
  10. 12.2.3 Sanofi Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  11. 12.2.4 Sanofi Yellow Nail Syndrome Treatment Product Portfolio
  12. 12.2.5 Sanofi Recent Developments
  13. 12.3 Johnson & Johnson
  14. 12.3.1 Johnson & Johnson Company Information
  15. 12.3.2 Johnson & Johnson Business Overview
  16. 12.3.3 Johnson & Johnson Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  17. 12.3.4 Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio
  18. 12.3.5 Johnson & Johnson Recent Developments
  19. 12.4 Novartis
  20. 12.4.1 Novartis Company Information
  21. 12.4.2 Novartis Business Overview
  22. 12.4.3 Novartis Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  23. 12.4.4 Novartis Yellow Nail Syndrome Treatment Product Portfolio
  24. 12.4.5 Novartis Recent Developments
  25. 12.5 Merck
  26. 12.5.1 Merck Company Information
  27. 12.5.2 Merck Business Overview
  28. 12.5.3 Merck Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  29. 12.5.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  30. 12.5.5 Merck Recent Developments
  31. 12.6 Merck
  32. 12.6.1 Merck Company Information
  33. 12.6.2 Merck Business Overview
  34. 12.6.3 Merck Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  35. 12.6.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  36. 12.6.5 Merck Recent Developments
  37. 12.7 Mylan
  38. 12.7.1 Mylan Company Information
  39. 12.7.2 Mylan Business Overview
  40. 12.7.3 Mylan Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  41. 12.7.4 Mylan Yellow Nail Syndrome Treatment Product Portfolio
  42. 12.7.5 Mylan Recent Developments
  43. 12.8 Roche
  44. 12.8.1 Roche Company Information
  45. 12.8.2 Roche Business Overview
  46. 12.8.3 Roche Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  47. 12.8.4 Roche Yellow Nail Syndrome Treatment Product Portfolio
  48. 12.8.5 Roche Recent Developments
  49. 12.9 Pfizer
  50. 12.9.1 Pfizer Company Information
  51. 12.9.2 Pfizer Business Overview
  52. 12.9.3 Pfizer Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  53. 12.9.4 Pfizer Yellow Nail Syndrome Treatment Product Portfolio
  54. 12.9.5 Pfizer Recent Developments
  55. 12.10 GlaxoSmithKline
  56. 12.10.1 GlaxoSmithKline Company Information
  57. 12.10.2 GlaxoSmithKline Business Overview
  58. 12.10.3 GlaxoSmithKline Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  59. 12.10.4 GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio
  60. 12.10.5 GlaxoSmithKline Recent Developments
  61. 12.11 Bayer
  62. 12.11.1 Bayer Company Information
  63. 12.11.2 Bayer Business Overview
  64. 12.11.3 Bayer Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  65. 12.11.4 Bayer Yellow Nail Syndrome Treatment Product Portfolio
  66. 12.11.5 Bayer Recent Developments
  67. 12.12 AstraZeneca
  68. 12.12.1 AstraZeneca Company Information
  69. 12.12.2 AstraZeneca Business Overview
  70. 12.12.3 AstraZeneca Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  71. 12.12.4 AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio
  72. 12.12.5 AstraZeneca Recent Developments
  73. 12.13 Teva Pharmaceutical
  74. 12.13.1 Teva Pharmaceutical Company Information
  75. 12.13.2 Teva Pharmaceutical Business Overview
  76. 12.13.3 Teva Pharmaceutical Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  77. 12.13.4 Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  78. 12.13.5 Teva Pharmaceutical Recent Developments
  79. 12.14 Sun Pharmaceutical
  80. 12.14.1 Sun Pharmaceutical Company Information
  81. 12.14.2 Sun Pharmaceutical Business Overview
  82. 12.14.3 Sun Pharmaceutical Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  83. 12.14.4 Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  84. 12.14.5 Sun Pharmaceutical Recent Developments
  85. 12.15 Sumitomo Corporation
  86. 12.15.1 Sumitomo Corporation Company Information
  87. 12.15.2 Sumitomo Corporation Business Overview
  88. 12.15.3 Sumitomo Corporation Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  89. 12.15.4 Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio
  90. 12.15.5 Sumitomo Corporation Recent Developments
  91. 12.16 Enzon Pharmaceuticals
  92. 12.16.1 Enzon Pharmaceuticals Company Information
  93. 12.16.2 Enzon Pharmaceuticals Business Overview
  94. 12.16.3 Enzon Pharmaceuticals Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  95. 12.16.4 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio
  96. 12.16.5 Enzon Pharmaceuticals Recent Developments
  97. 12.17 Cipla
  98. 12.17.1 Cipla Company Information
  99. 12.17.2 Cipla Business Overview
  100. 12.17.3 Cipla Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  101. 12.17.4 Cipla Yellow Nail Syndrome Treatment Product Portfolio
  102. 12.17.5 Cipla Recent Developments
  103. 12.18 Allergan
  104. 12.18.1 Allergan Company Information
  105. 12.18.2 Allergan Business Overview
  106. 12.18.3 Allergan Revenue in Yellow Nail Syndrome Treatment Business (2021-2026)
  107. 12.18.4 Allergan Yellow Nail Syndrome Treatment Product Portfolio
  108. 12.18.5 Allergan Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst